<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31270C3B-CBC7-4D8D-90FA-98CF97F8310F"><gtr:id>31270C3B-CBC7-4D8D-90FA-98CF97F8310F</gtr:id><gtr:name>l'Institut de Recherche Biom?dicale des Arm?es</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0F70942C-A9E8-4810-881A-96C383123468"><gtr:id>0F70942C-A9E8-4810-881A-96C383123468</gtr:id><gtr:name>University of Occupational and Environmental Health</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/743B0403-114A-4062-A04B-26B6E57DE502"><gtr:id>743B0403-114A-4062-A04B-26B6E57DE502</gtr:id><gtr:name>Columbia University</gtr:name><gtr:address><gtr:line1>Columbia University</gtr:line1><gtr:line2>2960 Broadway</gtr:line2><gtr:line4>New York</gtr:line4><gtr:line5>NY 10027-6902</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C83AFE0C-D1D9-49C5-8225-00BFF123B425"><gtr:id>C83AFE0C-D1D9-49C5-8225-00BFF123B425</gtr:id><gtr:name>Chung Shan Medical University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4F9C330B-1CF9-4614-BCBE-D59880EBA834"><gtr:id>4F9C330B-1CF9-4614-BCBE-D59880EBA834</gtr:id><gtr:name>Flemish Institute for Technological Research (VITO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4F10851E-F3F5-4F2F-8587-7EA8086F2177"><gtr:id>4F10851E-F3F5-4F2F-8587-7EA8086F2177</gtr:id><gtr:name>University of Parma</gtr:name><gtr:address><gtr:line1>Universita degli studi di Parma</gtr:line1><gtr:line2>via Universita 12</gtr:line2><gtr:postCode>43121</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2335198B-5792-44AB-BA60-2B4CE81373DE"><gtr:id>2335198B-5792-44AB-BA60-2B4CE81373DE</gtr:id><gtr:name>Laboratoire Philippe Auguste</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7C7E9171-340D-4487-ACF4-B45B22DE98AA"><gtr:id>7C7E9171-340D-4487-ACF4-B45B22DE98AA</gtr:id><gtr:name>Institute of Experimental Medicine AS CR</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1FCF297-5E30-4BD4-B1E6-2BC2D759043E"><gtr:id>D1FCF297-5E30-4BD4-B1E6-2BC2D759043E</gtr:id><gtr:name>Forsite Diagnostics</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C35DED20-1149-4F38-94E6-CA8A525B7D33"><gtr:id>C35DED20-1149-4F38-94E6-CA8A525B7D33</gtr:id><gtr:name>Nicolaus Copernicus University</gtr:name><gtr:address><gtr:line1>Nicolaus Copernicus University</gtr:line1><gtr:postCode>87-100</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82200E1A-04DA-42F5-80F3-B0FF026643BD"><gtr:id>82200E1A-04DA-42F5-80F3-B0FF026643BD</gtr:id><gtr:name>University of Copenhagen</gtr:name><gtr:address><gtr:line1>Norregade 10</gtr:line1><gtr:line2>Postboks 2177</gtr:line2><gtr:line4>Copenhagen K</gtr:line4><gtr:line5>DK-1017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2B4890EC-5704-4F99-AE13-CC1371378CBB"><gtr:id>2B4890EC-5704-4F99-AE13-CC1371378CBB</gtr:id><gtr:name>Copenhagen University Hospital</gtr:name><gtr:address><gtr:line1>Kettegaard Alle 30</gtr:line1><gtr:postCode>DK-2650</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CCE20615-F558-4E68-B218-E9FF8AEB363D"><gtr:id>CCE20615-F558-4E68-B218-E9FF8AEB363D</gtr:id><gtr:name>National University of Defense Technolog</gtr:name><gtr:address><gtr:line1>National University of Defense Tech</gtr:line1><gtr:line2>Changsha</gtr:line2><gtr:postCode>410073</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>China</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/56DE87F1-C5B8-47FD-8E5D-8797587C15E5"><gtr:id>56DE87F1-C5B8-47FD-8E5D-8797587C15E5</gtr:id><gtr:name>Ege University</gtr:name><gtr:address><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4079917E-E95F-41EB-A1AE-2DA44B9EF9BC"><gtr:id>4079917E-E95F-41EB-A1AE-2DA44B9EF9BC</gtr:id><gtr:name>Biotage</gtr:name><gtr:address><gtr:line1>Headquarters Biotage AB and business</gtr:line1><gtr:line2>area Biosystems</gtr:line2><gtr:line3>Kungsgatan 76</gtr:line3><gtr:postCode>SE-753 18</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EEAA6BC7-A72B-44F5-8341-46ABDC3BB4CC"><gtr:id>EEAA6BC7-A72B-44F5-8341-46ABDC3BB4CC</gtr:id><gtr:name>European Space Agency</gtr:name><gtr:address><gtr:line1>8-10 rue Mario Nikis</gtr:line1><gtr:postCode>F-75738</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6DCA7B7A-0111-4A7C-95CC-DEAD58B89132"><gtr:id>6DCA7B7A-0111-4A7C-95CC-DEAD58B89132</gtr:id><gtr:name>University of Stockholm</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E67597F-C9AB-4ED2-BB87-FB1D1FC6FB6D"><gtr:id>4E67597F-C9AB-4ED2-BB87-FB1D1FC6FB6D</gtr:id><gtr:name>University of Heidelberg</gtr:name><gtr:address><gtr:line1>University of Heidelberg</gtr:line1><gtr:line4>Heidelberg</gtr:line4><gtr:postCode>D-69120</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E5BF932F-2229-4B00-B9AE-E87574F31B9F"><gtr:id>E5BF932F-2229-4B00-B9AE-E87574F31B9F</gtr:id><gtr:name>Japan Institute for the Control of Aging (JaICA)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5589D756-E334-47E6-9A29-7932ED64B2A1"><gtr:id>5589D756-E334-47E6-9A29-7932ED64B2A1</gtr:id><gtr:name>Valencia University</gtr:name><gtr:address><gtr:line1>Valencia University</gtr:line1><gtr:line2>Avda. Bianca Ibanez 13</gtr:line2><gtr:line4>Valencia</gtr:line4><gtr:postCode>46010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:department>Cancer Studies and Molecular Medicine</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31270C3B-CBC7-4D8D-90FA-98CF97F8310F"><gtr:id>31270C3B-CBC7-4D8D-90FA-98CF97F8310F</gtr:id><gtr:name>l'Institut de Recherche Biom?dicale des Arm?es</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0F70942C-A9E8-4810-881A-96C383123468"><gtr:id>0F70942C-A9E8-4810-881A-96C383123468</gtr:id><gtr:name>University of Occupational and Environmental Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/743B0403-114A-4062-A04B-26B6E57DE502"><gtr:id>743B0403-114A-4062-A04B-26B6E57DE502</gtr:id><gtr:name>Columbia University</gtr:name><gtr:address><gtr:line1>Columbia University</gtr:line1><gtr:line2>2960 Broadway</gtr:line2><gtr:line4>New York</gtr:line4><gtr:line5>NY 10027-6902</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C83AFE0C-D1D9-49C5-8225-00BFF123B425"><gtr:id>C83AFE0C-D1D9-49C5-8225-00BFF123B425</gtr:id><gtr:name>Chung Shan Medical University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4F9C330B-1CF9-4614-BCBE-D59880EBA834"><gtr:id>4F9C330B-1CF9-4614-BCBE-D59880EBA834</gtr:id><gtr:name>Flemish Institute for Technological Research (VITO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4F10851E-F3F5-4F2F-8587-7EA8086F2177"><gtr:id>4F10851E-F3F5-4F2F-8587-7EA8086F2177</gtr:id><gtr:name>University of Parma</gtr:name><gtr:address><gtr:line1>Universita degli studi di Parma</gtr:line1><gtr:line2>via Universita 12</gtr:line2><gtr:postCode>43121</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2335198B-5792-44AB-BA60-2B4CE81373DE"><gtr:id>2335198B-5792-44AB-BA60-2B4CE81373DE</gtr:id><gtr:name>Laboratoire Philippe Auguste</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7C7E9171-340D-4487-ACF4-B45B22DE98AA"><gtr:id>7C7E9171-340D-4487-ACF4-B45B22DE98AA</gtr:id><gtr:name>Institute of Experimental Medicine AS CR</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1FCF297-5E30-4BD4-B1E6-2BC2D759043E"><gtr:id>D1FCF297-5E30-4BD4-B1E6-2BC2D759043E</gtr:id><gtr:name>Forsite Diagnostics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C35DED20-1149-4F38-94E6-CA8A525B7D33"><gtr:id>C35DED20-1149-4F38-94E6-CA8A525B7D33</gtr:id><gtr:name>Nicolaus Copernicus University</gtr:name><gtr:address><gtr:line1>Nicolaus Copernicus University</gtr:line1><gtr:postCode>87-100</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82200E1A-04DA-42F5-80F3-B0FF026643BD"><gtr:id>82200E1A-04DA-42F5-80F3-B0FF026643BD</gtr:id><gtr:name>University of Copenhagen</gtr:name><gtr:address><gtr:line1>Norregade 10</gtr:line1><gtr:line2>Postboks 2177</gtr:line2><gtr:line4>Copenhagen K</gtr:line4><gtr:line5>DK-1017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2B4890EC-5704-4F99-AE13-CC1371378CBB"><gtr:id>2B4890EC-5704-4F99-AE13-CC1371378CBB</gtr:id><gtr:name>Copenhagen University Hospital</gtr:name><gtr:address><gtr:line1>Kettegaard Alle 30</gtr:line1><gtr:postCode>DK-2650</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CCE20615-F558-4E68-B218-E9FF8AEB363D"><gtr:id>CCE20615-F558-4E68-B218-E9FF8AEB363D</gtr:id><gtr:name>National University of Defense Technolog</gtr:name><gtr:address><gtr:line1>National University of Defense Tech</gtr:line1><gtr:line2>Changsha</gtr:line2><gtr:postCode>410073</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>China</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/56DE87F1-C5B8-47FD-8E5D-8797587C15E5"><gtr:id>56DE87F1-C5B8-47FD-8E5D-8797587C15E5</gtr:id><gtr:name>Ege University</gtr:name><gtr:address><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4079917E-E95F-41EB-A1AE-2DA44B9EF9BC"><gtr:id>4079917E-E95F-41EB-A1AE-2DA44B9EF9BC</gtr:id><gtr:name>Biotage</gtr:name><gtr:address><gtr:line1>Headquarters Biotage AB and business</gtr:line1><gtr:line2>area Biosystems</gtr:line2><gtr:line3>Kungsgatan 76</gtr:line3><gtr:postCode>SE-753 18</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EEAA6BC7-A72B-44F5-8341-46ABDC3BB4CC"><gtr:id>EEAA6BC7-A72B-44F5-8341-46ABDC3BB4CC</gtr:id><gtr:name>European Space Agency</gtr:name><gtr:address><gtr:line1>8-10 rue Mario Nikis</gtr:line1><gtr:postCode>F-75738</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6DCA7B7A-0111-4A7C-95CC-DEAD58B89132"><gtr:id>6DCA7B7A-0111-4A7C-95CC-DEAD58B89132</gtr:id><gtr:name>University of Stockholm</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E67597F-C9AB-4ED2-BB87-FB1D1FC6FB6D"><gtr:id>4E67597F-C9AB-4ED2-BB87-FB1D1FC6FB6D</gtr:id><gtr:name>University of Heidelberg</gtr:name><gtr:address><gtr:line1>University of Heidelberg</gtr:line1><gtr:line4>Heidelberg</gtr:line4><gtr:postCode>D-69120</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E5BF932F-2229-4B00-B9AE-E87574F31B9F"><gtr:id>E5BF932F-2229-4B00-B9AE-E87574F31B9F</gtr:id><gtr:name>Japan Institute for the Control of Aging (JaICA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5589D756-E334-47E6-9A29-7932ED64B2A1"><gtr:id>5589D756-E334-47E6-9A29-7932ED64B2A1</gtr:id><gtr:name>Valencia University</gtr:name><gtr:address><gtr:line1>Valencia University</gtr:line1><gtr:line2>Avda. Bianca Ibanez 13</gtr:line2><gtr:line4>Valencia</gtr:line4><gtr:postCode>46010</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Spain</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/037EBED0-BC16-4F18-8202-607F34964200"><gtr:id>037EBED0-BC16-4F18-8202-607F34964200</gtr:id><gtr:firstName>Marcus</gtr:firstName><gtr:otherNames>Stanley</gtr:otherNames><gtr:surname>Cooke</gtr:surname><gtr:orcidId>0000-0003-0369-862X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9B9A2973-7652-473F-935B-326F3CBD5901"><gtr:id>9B9A2973-7652-473F-935B-326F3CBD5901</gtr:id><gtr:firstName>Gary</gtr:firstName><gtr:otherNames>P</gtr:otherNames><gtr:surname>Dowthwaite</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1001808"><gtr:id>819E2510-40DA-4690-A930-A90BF376510E</gtr:id><gtr:title>Development of validated assays for the evaluation oxidative stress in health and disease.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G1001808</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Overarching objective: a successful partnership between Leicester and Biotage.

1. Timing. Leicester?s biomarker research fits perfectly with Biotage?s planned move into

the biological sciences market. The collaboration with Leicester will provide reputation and

assays, generating a strong and credible market presence.

2. Expertise. Leicester has an international reputation in the field of biomarkers, mass

spectrometry, and biomarkers of oxidative stress. However, to expand the repertoire of DNA

lesions studied, and to develop high throughput analysis, requires knowledge of SPE

chemistry, and associated equipment. Biotage has extensive expertise and is the market

leader in the development of SPE chemistry and technology.

3. Exchange. Items (1) and (2) provide significant scope for technology and knowledge

exchange.

4. Economic benefits. Oxidative stress receives widespread interest, yet there is a

paucity of robust commercial assays. This collaboration represents an important route, by

generating competitive advantage, to establish a significant stake in a growing market .

Research excellence. The proposal builds upon research excellence in oxidative stress and

biomarkers represented by MSC/Leicester. MSC leads of one of the foremost oxidative stress

groups in the UK, illustrated by numerous awards, and a total of 76 publications; 55 in peerreviewed

journals (48% in the top oxidative stress journals) and 21 book

chapters/reviews/commentaries including co-editing one book. MSC is chair of the EU FP6

funded international ESCULA (www.escula.org) project comprising &amp;gt; 30 labs/SMEs, validating

urinary DNA biomarkers for large-scale human studies.

Importance. DNA oxidation, derived from both endogenous and exogenous sources, is

considered important in the pathogenesis of numerous diseases with significant worldwide

impact e.g. cancer, cardiovascular and neurodegenerative disease, hence strong interest from

academia and industry. Widely used as biomarkers of generalised oxidative stress, these

markers may also inform on DNA repair, crucial to genome protection. However, there is a

paucity of robust biomarker assays validated to GCLP, which largely confines the potential

market to non-clinical, academic research. The proposed partnership is uniquely placed to

address this gap in a significant market, to provide robust oxidative stress assays that could

be used to address numerous MRC strategic research areas. For example: Stratification of

phenotype (e.g. asthma); Tracking response to intervention (e.g. chemoprevention);

Measure, understand and modify environmental and inherited influences on health (e.g.

exposure to UVR or airborne pollutants); Exploitation of world leading position in hypothesisgenerating

science to deliver improved health (e.g. high-throughput assays of oxidative stress

for molecular epidemiology); Development of new interventions (DNA repair targets in

cancer).

Justification for the collaborating partner chosen. Biotage are seeking to make a large-scale

move into the biological science applications market. This will add to their existing portfolio

(Forensic, Environmental and Agrochemical and Food). To make this move credible, and

demonstrate application for their products to the biological/health sciences Biotage requires a

pairing with a prominent academic group. We request support to determine the potential size

of the collaboration between Leicester and Biotage. This will include generation of pilot data

from novel assays to support Leicester?s biomarker interests and Biotage?s proposed move

into the biological science applications market.</gtr:technicalSummary><gtr:fund><gtr:end>2012-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>61344</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Experimental Medicine AS CR</gtr:collaboratingOrganisation><gtr:country>Czech Republic</gtr:country><gtr:department>Laboratory of Genetic Ecotoxicology</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>2FA5F50E-901E-45CD-A244-541963A5BC09</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-5</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Biotage</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Biotage</gtr:description><gtr:id>7364742D-A9EA-4BFC-904A-78B5A6AF1394</gtr:id><gtr:impact>Lam, PMW., Mistry, V., Marczylo, TH., Konje, JC., Evans, MD. and Cooke, MS. (2012) Rapid measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine in human biological matrices using ultra high performance liquid chromatography tandem mass spectrometry. Free Radic. Biol. Med. 52, 2057-2063.

Extraction of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) from biological fluids using ISOLUTE ENV+. Biotage product application note.</gtr:impact><gtr:outcomeId>fcndrxkaTR6-1</gtr:outcomeId><gtr:partnerContribution>Biotage made significant in-kind contributions and access to their facilities, equipment and technical expertise.</gtr:partnerContribution><gtr:piContribution>Expertise in understanding the sources and analysis of DNA damage products in extracellular matrices. This resulted in a novel UHPLC-MS/MS method for 8-oxo-7,8-dihydro-2'-deoxyguanosine in a variety of human, biological matrices (PMC3404459). This then generated a product application note for Biotage.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Copenhagen University Hospital</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:department>Laboratory of Clinical Pharmacology</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>758C0021-ACE8-4990-90B2-6B5FB1DCF64D</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-3</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Space Agency</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>ESA Laboratories</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>E68452EF-270D-46AE-94E0-5C4F3306FAB5</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-17</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Columbia University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Environmental Health Sciences</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>7EBF5815-6CB2-4900-A71A-F240CED01087</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-19</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Valencia</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Biochemistry and Molecular Biology Department</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>F319D28E-5C56-427B-85D3-9DEBF6D064DC</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-11</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Flemish Institute for Technological Research (VITO)</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:department>Environmental Risk and Health Unit</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>4EEF6965-851B-42E0-9FC5-09EC8E063FFF</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-4</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Laboratoire Philippe Auguste</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>ESCULA</gtr:description><gtr:id>FF76DF7F-8EF4-4ADC-AD9F-ED4319C92633</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-6</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>NIBOIRE</gtr:description><gtr:id>FC285C91-17D4-4DAE-8DA0-0510FA0233FF</gtr:id><gtr:impact>Confidential</gtr:impact><gtr:outcomeId>FwPAusKwL99-3</gtr:outcomeId><gtr:partnerContribution>Expertise in specific technologies, health risk assessment and radiobiology.</gtr:partnerContribution><gtr:piContribution>Leadership of the consortium, biomarkers of oxidative stress expertise</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nicolaus Copernicus University in Torun</gtr:collaboratingOrganisation><gtr:country>Poland, Republic of</gtr:country><gtr:department>Department of Clinical Biochemistry</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>4437D8DD-F984-46BE-9D29-529D6398933A</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-10</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chung Shan Medical University</gtr:collaboratingOrganisation><gtr:country>Taiwan</gtr:country><gtr:description>ESCULA</gtr:description><gtr:id>DB85AB98-2C13-476E-B37B-1A9606DD574E</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-14</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Parma</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>National Institute for Insurance against Accidents at Work</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>274ABD3E-F09D-4381-99DB-1D01C12A8BAC</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-8</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Copenhagen</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:department>Department of Public Health</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>932B60AC-4EB2-411B-ADBC-03CF55BEF973</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-2</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Sections for Metals and Health</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>5AC7AA3F-C3C1-4306-99F0-7A650F1B333C</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-12</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Stockholm University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Department of Genetics, Microbiology and Toxicology</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>F9DF708E-2F48-457B-BAF1-E28FA9D888E6</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-13</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Occupational and Environmental Health</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:department>Department of Environmental Health Engineering</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>F75A8A54-4E0D-4DDE-92FC-B31D8488748B</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-9</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Japan Institute for the Control of Aging (JaICA)</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>NIBOIRE</gtr:description><gtr:id>2595E517-6339-4E8B-8415-A96D0BA3F040</gtr:id><gtr:impact>Confidential</gtr:impact><gtr:outcomeId>FwPAusKwL99-2</gtr:outcomeId><gtr:partnerContribution>Expertise in specific technologies, health risk assessment and radiobiology.</gtr:partnerContribution><gtr:piContribution>Leadership of the consortium, biomarkers of oxidative stress expertise</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ege University</gtr:collaboratingOrganisation><gtr:country>Turkey, Republic of</gtr:country><gtr:department>Department of Pharmaceutical Toxicology</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>BC24857D-9F62-4932-9B9E-2724008EDC75</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-16</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National University of Defense Technology</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>ESCULA</gtr:description><gtr:id>041E56A1-3213-4417-A5A3-CBD18F4685A2</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-15</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>l'Institut de Recherche Biom?dicale des Arm?es</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>NIBOIRE</gtr:description><gtr:id>40AD65EA-AA31-4C32-BBDE-157592B2A267</gtr:id><gtr:impact>Confidential</gtr:impact><gtr:outcomeId>FwPAusKwL99-4</gtr:outcomeId><gtr:partnerContribution>Expertise in specific technologies, health risk assessment and radiobiology.</gtr:partnerContribution><gtr:piContribution>Leadership of the consortium, biomarkers of oxidative stress expertise</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Forsite Diagnostics</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>NIBOIRE</gtr:description><gtr:id>09D75703-AB80-4E94-9F08-C31BE276E2A0</gtr:id><gtr:impact>Confidential</gtr:impact><gtr:outcomeId>FwPAusKwL99-1</gtr:outcomeId><gtr:partnerContribution>Expertise in specific technologies, health risk assessment and radiobiology.</gtr:partnerContribution><gtr:piContribution>Leadership of the consortium, biomarkers of oxidative stress expertise</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Parma</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Department of Clinical &amp; Experimental Medicine</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>0A238B8A-0AB4-425A-B526-EAB5C19DC0AA</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-7</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Heidelberg University</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute for Occupational and Social Medicine</gtr:department><gtr:description>ESCULA</gtr:description><gtr:id>3256EDE0-49DB-4E9D-B054-69743BA34D7E</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-1</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Japan Institute for the Control of Aging (JaICA)</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>ESCULA</gtr:description><gtr:id>2A423C48-1FD6-46EE-A2E7-2465793A9B15</gtr:id><gtr:impact>Grants and publications</gtr:impact><gtr:outcomeId>sf336MmhUzD-18</gtr:outcomeId><gtr:partnerContribution>Contributed to grant applications, publications and inter-laboratory validation studies.</gtr:partnerContribution><gtr:piContribution>Chaired the European Standards Committee of Urinary (DNA) Lesion Analysis (ESCULA). Led and contributed to grant applications and publications plus coordinated inter-laboratory validation studies.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>9964</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University of Leicester Innovation Fellowship</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>University of Leicester</gtr:fundingOrg><gtr:id>7A1FCB85-547F-4211-A7B3-D79031B5443E</gtr:id><gtr:outcomeId>Zdo1MKBMqqS</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Use of ISOLUTE ENV+ for the extraction of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) from biological fluids. MRC most recent principle source of funding for this development.</gtr:description><gtr:id>EEF50E04-6BD4-4C1B-BEF4-9FE872B33D0C</gtr:id><gtr:impact>Increased the speed and ease of sample throughput</gtr:impact><gtr:outcomeId>ZARzoszJJG5</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>ISOLUTE ENV+</gtr:title><gtr:type>Support Tool - For Medical Intervention</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Rapid UHPLC-MS/MS method for 8-oxodG in a variety of human biological matrices e.g. urine, serum, plasma, seminal plasma, amniotic fluid, peritoneal fluid.</gtr:description><gtr:id>7C38BD0E-0CAC-4975-AA35-15040E251F02</gtr:id><gtr:impact>Urine volume and assay time have both been significantly decreased compared to exisitng methods. 8-oxodG had not been previously detected in some of the above matrices.</gtr:impact><gtr:outcomeId>Gc2xbtRiuQp</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>UHPLC-MS/MS of 8-oxodG</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7101617F-15E5-4868-9138-E1A10B028A21</gtr:id><gtr:title>Rapid measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine in human biological matrices using ultra-high-performance liquid chromatography-tandem mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/943960056928bac0d4ba361497a475ce"><gtr:id>943960056928bac0d4ba361497a475ce</gtr:id><gtr:otherNames>Lam PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>MCPhT2yupG6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9122AA0-9A62-4BB7-9976-77120E2ABE3C</gtr:id><gtr:title>Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids.</gtr:title><gtr:parentPublicationTitle>Free radical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fd0bd45d18b3bf4ff73d66f38e0c80a"><gtr:id>9fd0bd45d18b3bf4ff73d66f38e0c80a</gtr:id><gtr:otherNames>Cadet J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1029-2470</gtr:issn><gtr:outcomeId>pm_15421_21_22263561</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1001808</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>